332 related articles for article (PubMed ID: 26136424)
1. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
Paschall AV; Yang D; Lu C; Choi JH; Li X; Liu F; Figueroa M; Oberlies NH; Pearce C; Bollag WB; Nayak-Kapoor A; Liu K
J Immunol; 2015 Aug; 195(4):1868-82. PubMed ID: 26136424
[TBL] [Abstract][Full Text] [Related]
2. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth.
Lu C; Klement JD; Yang D; Albers T; Lebedyeva IO; Waller JL; Liu K
Cancer Lett; 2020 Apr; 476():87-96. PubMed ID: 32061753
[TBL] [Abstract][Full Text] [Related]
3. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
Liu F; Liu Q; Yang D; Bollag WB; Robertson K; Wu P; Liu K
Cancer Res; 2011 Nov; 71(21):6807-16. PubMed ID: 21911457
[TBL] [Abstract][Full Text] [Related]
4. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
Yang D; Torres CM; Bardhan K; Zimmerman M; McGaha TL; Liu K
J Immunol; 2012 May; 188(9):4441-9. PubMed ID: 22461695
[TBL] [Abstract][Full Text] [Related]
5. SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.
Lu C; Yang D; Klement JD; Oh IK; Savage NM; Waller JL; Colby AH; Grinstaff MW; Oberlies NH; Pearce CJ; Xie Z; Kulp SK; Coss CC; Phelps MA; Albers T; Lebedyeva IO; Liu K
Cancer Immunol Res; 2019 Mar; 7(3):414-427. PubMed ID: 30610059
[TBL] [Abstract][Full Text] [Related]
6. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
Lu C; Yang D; Sabbatini ME; Colby AH; Grinstaff MW; Oberlies NH; Pearce C; Liu K
BMC Cancer; 2018 Feb; 18(1):149. PubMed ID: 29409480
[TBL] [Abstract][Full Text] [Related]
7. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
9. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.
Lu C; Paschall AV; Shi H; Savage N; Waller JL; Sabbatini ME; Oberlies NH; Pearce C; Liu K
J Natl Cancer Inst; 2017 Jan; 109(6):. PubMed ID: 28131992
[TBL] [Abstract][Full Text] [Related]
10. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
11. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
12. Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
Kang KA; Piao MJ; Ryu YS; Kang HK; Chang WY; Keum YS; Hyun JW
Oncotarget; 2016 Jun; 7(26):40594-40620. PubMed ID: 27259240
[TBL] [Abstract][Full Text] [Related]
13. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
[TBL] [Abstract][Full Text] [Related]
15. CK2 downregulation induces senescence-associated heterochromatic foci formation through activating SUV39h1 and inactivating G9a.
Park JW; Kim JJ; Bae YS
Biochem Biophys Res Commun; 2018 Oct; 505(1):67-73. PubMed ID: 30241941
[TBL] [Abstract][Full Text] [Related]
16. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
17. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex.
Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S
Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054
[TBL] [Abstract][Full Text] [Related]
18. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.
Mozzetta C; Pontis J; Fritsch L; Robin P; Portoso M; Proux C; Margueron R; Ait-Si-Ali S
Mol Cell; 2014 Jan; 53(2):277-89. PubMed ID: 24389103
[TBL] [Abstract][Full Text] [Related]
19. Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.
Coe GL; Redd PS; Paschall AV; Lu C; Gu L; Cai H; Albers T; Lebedyeva IO; Liu K
Sci Rep; 2016 Aug; 6():30816. PubMed ID: 27487939
[TBL] [Abstract][Full Text] [Related]
20. Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a.
Zhang X; Wu J; Choiniere J; Yang Z; Huang Y; Bennett J; Wang L
Toxicol Appl Pharmacol; 2016 Aug; 304():42-7. PubMed ID: 27217333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
